RXi Pharma (RXII) Announces 2.7M Common Registered Direct Offering at $6.00/Share
Tweet Send to a Friend
RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced today that it has obtained commitments from several investors to purchase 2.7 million shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
